Breaking News Instant updates and real-time market news.

EVH

Evolent Health

$18.95

0.25 (1.34%)

07:42
11/21/16
11/21
07:42
11/21/16
07:42

Leerink continues positive on Evolent Health heading into 2017

Leerink analyst David Larsen continues to be positive on Evolent Health heading into 2017, and says that management has consistently delivered on promises, including five new partner relationships in 2016, steady organic growth in lives-on-platform from existing customers, a high degree of recurring revenue and steady improvement in EBITDA. The analyst reiterated an Outperform rating on the stock but lowered his price target on the shares to $24 from $28.

  • 29

    Nov

EVH Evolent Health
$18.95

0.25 (1.34%)

11/07/16
ADAM
11/07/16
NO CHANGE
Target $30
ADAM
Buy
Evolent Health weakness a buying opportunity, says Canaccord
Canaccord analyst Richard Close recommends investors buy the recent weakness in Evolent Health as he does not believe the company has suffered the same "weak purchasing environment" that other companies have discussed in their recent earnings calls. Close expects another strong quarterly report for Evolent and believes the company offers a bright spot in healthcare. Close reiterated his Buy rating and $40 price target on Evolent Health shares ahead of the company's Q3 earnings report, which is scheduled for November 9.
11/10/16
COWN
11/10/16
NO CHANGE
Target $35
COWN
Outperform
Evolent Health price target raised to $35 from $30 at Cowen
Cowen analyst Charles Ryhee raised his price target on Evolent Health to $35 from $30 following strong Q3 results and revised its guidance to include Valance and Aldera. The analyst believes with the changes to the ACA as a result of the election, providers will look to companies like Evolent to help drive outcomes to improve reimbursement. Ryhee reiterated his Outperform rating on Evolent Health shares.
11/15/16
COWN
11/15/16
NO CHANGE
Target $35
COWN
Outperform
Evolent Health weakness offers attractive entry point, says Cowen
Cowen analyst Charles Rhyee believes the 10% pullback in Evolent Health shares since the election reflects concerns that repealing and replacing the ACA could mean there will be no more Medicaid expansion. However, he thinks the provision eliminating Medicaid expansion and the associated Federal Medical Assistance Percentages increase may not be included in the Republican ACA-repeal provisions. Also, Rhyee thinks a transition to value-based care will continue even if the ACA is repealed and replaced. He recommends buying amid the post-election weakness and reiterate his $35 price target and Outperform rating on the shares.
11/16/16
WBLR
11/16/16
NO CHANGE
WBLR
Outperform
William Blair calls Evolent top small-cap alpha generation idea
William Blair analyst Ryan Daniels listed his top 10 reasons for why the recent pullback in shares of Evolent Health creates a good entry point. Much of the post-quarter weakness relates to the recent election results, as investors weigh the uncertainty created by a Republican-controlled White House and Congress along with the party's objective to immediately repeal and replace the Affordable Care Act, Daniels tells investors in a research note. The analyst believes the "movement to value-based care in the United States will continue apace" and has "strong" bipartisan support. He also believes Evolent Health's momentum "is quite strong." It is unlikely that the new administration will disrupt the insurance markets so much that tens of millions of Americans suddenly lose coverage in 2019, Daniels tells investors in a research note. He calls Evolent his top small-cap alpha generation idea over the next 12 months and reiterates an Outperform rating on the name.

TODAY'S FREE FLY STORIES

CYOU

Changyou.com

$25.06

-0.06 (-0.24%)

05:38
02/21/17
02/21
05:38
02/21/17
05:38
Earnings
Changyou.com reports Q4 EPS 75c, consensus 65c »

Reports Q4 revenue $131M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

FCX

Freeport McMoRan

$14.91

-0.16 (-1.06%)

05:37
02/21/17
02/21
05:37
02/21/17
05:37
Initiation
Freeport McMoRan initiated  »

Freeport McMoRan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

SOHU

Sohu.com

$39.35

0.1 (0.25%)

05:36
02/21/17
02/21
05:36
02/21/17
05:36
Earnings
Sohu.com sees Q1 EPS ($1.80)-($1.55), consensus ($1.59) »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

SEMG

SemGroup

$40.05

0.15 (0.38%)

05:34
02/21/17
02/21
05:34
02/21/17
05:34
Initiation
SemGroup initiated  »

SemGroup reinstated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

SOHU

Sohu.com

$39.35

0.1 (0.25%)

05:34
02/21/17
02/21
05:34
02/21/17
05:34
Earnings
Sohu.com reports Q4 EPS ($1.79), consensus ($2.08) »

Reports Q4 revenue $412M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

JELD

JELD-WEN Holding

$29.48

0.48 (1.66%)

05:33
02/21/17
02/21
05:33
02/21/17
05:33
Initiation
JELD-WEN Holding initiated  »

JELD-WEN Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REVG

REV Group

$27.59

0.37 (1.36%)

05:32
02/21/17
02/21
05:32
02/21/17
05:32
Initiation
REV Group initiated  »

REV Group initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REVG

REV Group

$27.59

0.37 (1.36%)

05:32
02/21/17
02/21
05:32
02/21/17
05:32
Initiation
REV Group initiated  »

REV Group initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAG

Jagged Peak Energy

$13.50

-0.08 (-0.59%)

05:30
02/21/17
02/21
05:30
02/21/17
05:30
Initiation
Jagged Peak Energy initiated  »

Jagged Peak Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAG

Jagged Peak Energy

$13.50

-0.08 (-0.59%)

05:30
02/21/17
02/21
05:30
02/21/17
05:30
Initiation
Jagged Peak Energy initiated  »

Jagged Peak Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAG

Jagged Peak Energy

$13.50

-0.08 (-0.59%)

05:29
02/21/17
02/21
05:29
02/21/17
05:29
Initiation
Jagged Peak Energy initiated  »

Jagged Peak Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAG

Jagged Peak Energy

$13.50

-0.08 (-0.59%)

05:28
02/21/17
02/21
05:28
02/21/17
05:28
Initiation
Jagged Peak Energy initiated  »

Jagged Peak Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAG

Jagged Peak Energy

$13.50

-0.08 (-0.59%)

05:28
02/21/17
02/21
05:28
02/21/17
05:28
Initiation
Jagged Peak Energy initiated  »

Jagged Peak Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAG

Jagged Peak Energy

$13.50

-0.08 (-0.59%)

05:26
02/21/17
02/21
05:26
02/21/17
05:26
Initiation
Jagged Peak Energy initiated  »

Jagged Peak Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFLYY

Air France-KLM

$6.83

0.29 (4.43%)

05:25
02/21/17
02/21
05:25
02/21/17
05:25
Upgrade
Air France-KLM rating change  »

Air France-KLM upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENGGY

Enagas

$12.34

-0.0699 (-0.56%)

05:24
02/21/17
02/21
05:24
02/21/17
05:24
Downgrade
Enagas rating change  »

Enagas downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRBP

Corbus Pharmaceuticals

$8.85

0.55 (6.63%)

04:55
02/21/17
02/21
04:55
02/21/17
04:55
Conference/Events
Cantor Fitzgerald health/pharma analysts hold analyst/industry conference call »

Analysts, along with Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

04:55
02/21/17
02/21
04:55
02/21/17
04:55
Conference/Events
CLSA automotive analyst holds an analyst/industry conference call »

Analyst Rosner, along…

AGR

AVANGRID

$40.91

0.13 (0.32%)

04:55
02/21/17
02/21
04:55
02/21/17
04:55
Conference/Events
AVANGRID to hold a financial update »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 28

    Feb

LHCG

LHC Group

$48.30

0.12 (0.25%)

04:55
02/21/17
02/21
04:55
02/21/17
04:55
Conference/Events
LHC Group management to meet with Oppenheimer »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 21

    Mar

HNI

HNI Corporation

$46.09

0.04 (0.09%)

04:55
02/21/17
02/21
04:55
02/21/17
04:55
Conference/Events
HNI Corporation management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

KN

Knowles

$19.42

0.14 (0.73%)

04:55
02/21/17
02/21
04:55
02/21/17
04:55
Conference/Events
Knowles management to meet with Roth Capital »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

04:55
02/21/17
02/21
04:55
02/21/17
04:55
General news
Breaking General news story  »

Philadelphia Federal…

04:55
02/21/17
02/21
04:55
02/21/17
04:55
General news
Breaking General news story  »

San Francisco Federal…

04:55
02/21/17
02/21
04:55
02/21/17
04:55
Conference/Events
UBS to hold a field trip »

UBS Telecom Trip to…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.